A prospective epidemiological study of women as of 24 weeks of pregnancy, and their infants up to 1 year of age, to describe maternal, fetal and neonatal outcomes, pregnancy-related and neonatal/infant events of interest and the occurrence in neonates/infants of respiratory syncytial virus lower respiratory tract infections (RSV LRTI) | India Science, Technology & Innovation - ISTI Portal

×

Acces sibility Controls

A prospective epidemiological study of women as of 24 weeks of pregnancy, and their infants up to 1 year of age, to describe maternal, fetal and neonatal outcomes, pregnancy-related and neonatal/infant events of interest and the occurrence in neonates/infants of respiratory syncytial virus lower respiratory tract infections (RSV LRTI)

Implementing Organization

All India Institute of Medical Sciences

Principal Investigator

Dr Shashi Kant

Professor

|

All India Institute of Medical Sciences

Abstract

NA

Patents

NA

Achievements

NA

Outcome / Output

NA

Publications

NA

Related Research

Funding Organization

Funding Organization

Glaxo Smith Kline (GSK), Europe

Quick Information

Area of Research

Life Sciences & Biotechnology

Focus Area

Respiratory Health

Start Year

2019

End Year

2022

Sanction Amount

₹ 3.19 Cr

Status

Completed

Contact

skant76@gmail.com

Output

No. of Research Paper

00

Technologies (If Any)

00

No. of PhD Produced

NA

No. of Patents

Filed : 00

Grant : 00

Disclaimer: Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.

Latest Updates

Loading…